Telomerase reverse transcriptase (TERT) C228T mutation was detected in normal urothelium and urothelial dysplasia of patients with nonmuscle invasive bladder cancer (NMIBC) and may thus be a novel and useful prognostic factor for risk stratification of NMIBC. This evidence concerns the gene TERT and urothelial dysplasia.